134 related articles for article (PubMed ID: 27072905)
1. Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma.
Sturdivant JM; Royalty SM; Lin CW; Moore LA; Yingling JD; Laethem CL; Sherman B; Heintzelman GR; Kopczynski CC; deLong MA
Bioorg Med Chem Lett; 2016 May; 26(10):2475-2480. PubMed ID: 27072905
[TBL] [Abstract][Full Text] [Related]
2. The Application of Rho Kinase Inhibitors in the Management of Glaucoma.
Liu LC; Chen YH; Lu DW
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891764
[TBL] [Abstract][Full Text] [Related]
3. Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma.
Al-Humimat G; Marashdeh I; Daradkeh D; Kooner K
J Exp Pharmacol; 2021; 13():197-212. PubMed ID: 33664600
[TBL] [Abstract][Full Text] [Related]
4. [The effect of levobunolol eyedrops on trabecular outflow of aqueous humor in chronic simple glaucoma].
Călugăru M
Klin Monbl Augenheilkd; 1989 Mar; 194(3):164-9. PubMed ID: 2657200
[TBL] [Abstract][Full Text] [Related]
5. Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy.
Wang J; Wang H; Dang Y
Ophthalmol Ther; 2023 Dec; 12(6):2943-2957. PubMed ID: 37837578
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel N-Substituted Prolinamido Indazoles as Potent Rho Kinase Inhibitors and Vasorelaxation Agents.
Yao Y; Li R; Liu X; Yang F; Yang Y; Li X; Shi X; Yuan T; Fang L; Du G; Jiao X; Xie P
Molecules; 2017 Oct; 22(10):. PubMed ID: 29048389
[TBL] [Abstract][Full Text] [Related]
7. Rho Kinase Inhibitors: Strategies in Glaucoma Treatment in Older Adults.
Schehlein E; Robin A
Drugs Aging; 2024 May; 41(5):399-406. PubMed ID: 38416395
[TBL] [Abstract][Full Text] [Related]
8. Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity.
Hahmann C; Schroeter T
Cell Mol Life Sci; 2010 Jan; 67(2):171-7. PubMed ID: 19907920
[TBL] [Abstract][Full Text] [Related]
9. Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes.
Li G; Mukherjee D; Navarro I; Ashpole NE; Sherwood JM; Chang J; Overby DR; Yuan F; Gonzalez P; Kopczynski CC; Farsiu S; Stamer WD
Eur J Pharmacol; 2016 Sep; 787():20-31. PubMed ID: 27085895
[TBL] [Abstract][Full Text] [Related]
10. Netarsudil Increases Outflow Facility in Human Eyes Through Multiple Mechanisms.
Ren R; Li G; Le TD; Kopczynski C; Stamer WD; Gong H
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6197-6209. PubMed ID: 27842161
[TBL] [Abstract][Full Text] [Related]
11. Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma.
Lin CW; Sherman B; Moore LA; Laethem CL; Lu DW; Pattabiraman PP; Rao PV; deLong MA; Kopczynski CC
J Ocul Pharmacol Ther; 2018; 34(1-2):40-51. PubMed ID: 28609185
[TBL] [Abstract][Full Text] [Related]
12. Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma.
Lu LJ; Tsai JC; Liu J
Yale J Biol Med; 2017 Mar; 90(1):111-118. PubMed ID: 28356898
[TBL] [Abstract][Full Text] [Related]
13. Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
Serle JB; Katz LJ; McLaurin E; Heah T; Ramirez-Davis N; Usner DW; Novack GD; Kopczynski CC;
Am J Ophthalmol; 2018 Feb; 186():116-127. PubMed ID: 29199013
[TBL] [Abstract][Full Text] [Related]
14. Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury.
Shaw PX; Sang A; Wang Y; Ho D; Douglas C; Dia L; Goldberg JL
Exp Eye Res; 2017 May; 158():33-42. PubMed ID: 27443501
[TBL] [Abstract][Full Text] [Related]
15. Netarsudil Ophthalmic Solution 0.02%: First Global Approval.
Hoy SM
Drugs; 2018 Mar; 78(3):389-396. PubMed ID: 29453668
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans.
Kazemi A; McLaren JW; Kopczynski CC; Heah TG; Novack GD; Sit AJ
J Ocul Pharmacol Ther; 2018 Jun; 34(5):380-386. PubMed ID: 29469601
[TBL] [Abstract][Full Text] [Related]
17. Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.
Honjo M; Tanihara H
Jpn J Ophthalmol; 2018 Mar; 62(2):109-126. PubMed ID: 29445943
[TBL] [Abstract][Full Text] [Related]
18. Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension.
Tanna AP; Johnson M
Ophthalmology; 2018 Nov; 125(11):1741-1756. PubMed ID: 30007591
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
